Nuzenio

Pancreatic Cancer Trial

Pancreatic Cancer Trial news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 8 publisher sources 100/100 entity strength

Latest news

THE LUSTGARTEN FOUNDATION AND BREAK THROUGH CANCER ANNOUNCE NEW CLINICAL TRIAL EVALUATING KRAS-TARGETED IMMUNOTHERAPY STRATEGY FOR PANCREATIC CANCER - PR NewswirePR Newswire · Mon, 10 Aug 2026 13:50:00 GMT AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:53 GMT Elicio Study to Test Immunotherapy Before Pancreatic Cancer Surgery - Stock TitanStock Titan · Mon, 10 Aug 2026 12:00:00 GMT New drug delivers promising survival gains in pancreatic cancer - News-MedicalNews-Medical · Mon, 10 Aug 2026 03:11:00 GMT Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ - Chicago TribuneChicago Tribune · Sun, 09 Aug 2026 11:00:17 GMT Theriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:44:00 GMT Breakthrough Drug Brings Hope to Utah Grandfather with Pancreatic Cancer - University of Utah HealthUniversity of Utah Health · Thu, 06 Aug 2026 15:00:00 GMT FDA Accepts daraxonrasib Application for RAS-Mutant Pancreatic Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Thu, 06 Aug 2026 06:43:58 GMT

Timeline

Mon, 10 Aug 2026 13:50:00 GMTTHE LUSTGARTEN FOUNDATION AND BREAK THROUGH CANCER ANNOUNCE NEW CLINICAL TRIAL EVALUATING KRAS-TARGETED IMMUNOTHERAPY STRATEGY FOR PANCREATIC CANCER - PR Newswire

Mon, 10 Aug 2026 12:42:53 GMTAIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer - The Manila Times

Mon, 10 Aug 2026 12:00:00 GMTElicio Study to Test Immunotherapy Before Pancreatic Cancer Surgery - Stock Titan

Mon, 10 Aug 2026 03:11:00 GMTNew drug delivers promising survival gains in pancreatic cancer - News-Medical

Sun, 09 Aug 2026 11:00:17 GMTPatients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ - Chicago Tribune

Fri, 07 Aug 2026 06:44:00 GMTTheriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial Vanguard

Related explainers

HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

The Clinical Trial4 live mentions The Jerusalem Post3 live mentions TARGETED IMMUNOTHERAPY STRATEGY2 live mentions FOR PANCREATIC CANCER2 live mentions AIM ImmunoTech Reports2 live mentions Second Quarter2 live mentions Financial Results2 live mentions Highlights Significant Operational2 live mentions Execution Advancing Ampligen2 live mentions Toward Planned Phase2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Pancreatic Cancer Trial.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.